15th European AIDS Conference (EACS), 21-24 October 2015, Barcelona
1 December 2015. Related: Conference reports.
EACS 15 Barcelona 2015
Remarkable results with dolutegravir monotherapy
1 December 2015. Related: Conference reports, Antiretrovirals, Vaccines and microbicides.
First-line ART with dolutegravir plus 3TC: 24-week early results
1 December 2015. Related: Conference reports, Antiretrovirals, Treatment strategies.
New European HIV guidelines (October 2015): universal ART, first-line integrase and PrEP
1 December 2015. Related: Conference reports, Guidelines.
Impact of early ART on lung function: results on ART and COPD from START substudy
1 December 2015. Related: Conference reports, Coinfections and complications.
No difference in neuropsychological test results between early and delayed ART in START substudy
1 December 2015. Related: Conference reports, Side effects, Coinfections and complications.
Immediate ART in START linked to greater bone loss over three years
1 December 2015. Related: Conference reports, Side effects.
Price of MDR TB drugs could be greatly reduced with competitive generic manufacture
1 December 2015. Related: Conference reports, Treatment access, TB coinfection.
Potential for generic prices for 12 weeks sofosbuvir treatment to drop below US $300 and daclatasvir to US $23
1 December 2015. Related: Conference reports, Treatment access, Hepatitis coinfection.
Achieving viral suppression with HIV multi-drug resistance: peg-interferon and valaciclovir as part of rescue therapy
1 December 2015. Related: Conference reports, Antiretrovirals, Treatment strategies, Drug resistance.
French cohort of HIV transgender women highlights issues relating to HIV management
1 December 2015. Related: Conference reports.